onr:"swepub:oai:DiVA.org:umu-51470"
Search: onr:"swepub:oai:DiVA.org:umu-51470" > Activating ALK muta...
- 1 of 1
- Previous record
- Next record
- To hitlist
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
-
- Schönherr, Christina (author)
- Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten)
-
- Ruuth, Kristina (author)
- Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten)
-
- Yamazaki, Yasuo (author)
- Umeå universitet,Institutionen för molekylärbiologi (Medicinska fakulteten)
- show more...
- show less...
- (creator_code:org_t)
- 2011
- 2011
- English.
- In: Biochemical Journal. - 0264-6021 .- 1470-8728. ; 440, s. 405-413
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Mutations in the kinase domain of ALK (anaplastic lymphoma kinase) have recently been shown to be important for the progression of the childhood tumour neuroblastoma. In the present study we investigate six of the putative reported constitutively active ALK mutations, in positions G1128A, I1171N, F1174L, R1192P, F1245C and R1275Q. Our analyses were performed in cell-culture-based systems with both mouse and human ALK mutant variants and subsequently in a Drosophila melanogaster model system. Our investigation addressed the transforming potential of the putative gain-of-function ALK mutations as well as their signalling potential and the ability of two ATP-competitive inhibitors, Crizotinib (PF-02341066) and NVP-TAE684, to abrogate the activity of ALK. The results of the present study indicate that all mutations tested are of an activating nature and thus are implicated in tumour initiation or progression of neuroblastoma. Importantly for neuroblastoma patients, all ALK mutations used in the present study can be blocked by the inhibitors, although some mutants exhibited higher levels of drug sensitivity than others.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)
Keyword
- anaplastic lymphoma kinase (ALK)
- cancer
- Crizotinib
- gain-of-function mutation
- neuroblastoma
- NVP-TAE684
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Biochemical Journal (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Schönherr, Chris ...
- Ruuth, Kristina
- Yamazaki, Yasuo
- Eriksson, Theres ...
- Christensen, Jam ...
- Palmer, Ruth H
- show more...
- Hallberg, Bengt
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Cell and Molecul ...
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Medical Biotechn ...
- and Medical Biotechn ...
- Articles in the publication
- Biochemical Jour ...
- By the university
- Umeå University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
